These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High nontransferrin bound iron levels and heart disease in thalassemia major. Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD. Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228 [Abstract] [Full Text] [Related]
5. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients. Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C. Eur J Haematol; 2010 Jan 01; 84(1):72-8. PubMed ID: 19732137 [Abstract] [Full Text] [Related]
7. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT). Hilken A, Langebrake C, Wolschke C, Kersten JF, Rohde H, Nielsen P, Kröger N. Ann Hematol; 2017 Aug 01; 96(8):1379-1388. PubMed ID: 28585071 [Abstract] [Full Text] [Related]
8. A dimorphic blood film as a sign of the onset of iron-deficient erythropoiesis in megaloblastic anemia. Uprichard J, Dorling D, Bain BJ. Am J Hematol; 2012 Nov 01; 87(11):1046. PubMed ID: 22566238 [No Abstract] [Full Text] [Related]
12. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions. Kalleda N, Flace A, Altermatt P, Ingoglia G, Doucerain C, Nyffenegger N, Dürrenberger F, Manolova V. Haematologica; 2023 Oct 01; 108(10):2703-2714. PubMed ID: 37165842 [Abstract] [Full Text] [Related]
13. [The characteristics of iron metabolism in B12-deficient anemias (an evaluation of the functional status of megaloblastic erythropoiesis)]. Berliner GB, Kheĭfets LM. Ter Arkh; 1994 Oct 01; 66(7):58-61. PubMed ID: 7985132 [Abstract] [Full Text] [Related]
16. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients. Koonrungsesomboon N, Tantiworawit A, Phrommintikul A, Saekho S, Srichairattanakool S, Chattipakorn N. Hemoglobin; 2015 Oct 01; 39(4):281-6. PubMed ID: 26029793 [Abstract] [Full Text] [Related]
17. Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications. Belotti A, Duca L, Borin L, Realini S, Renso R, Parma M, Pioltelli P, Pogliani E, Cappellini MD. Leuk Res; 2015 Jan 01; 39(1):88-91. PubMed ID: 25435028 [Abstract] [Full Text] [Related]
19. Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population. Sugiura T, Dohi Y, Takase H, Fujii S, Seo Y, Ohte N. Medicine (Baltimore); 2021 Feb 19; 100(7):e24722. PubMed ID: 33607814 [Abstract] [Full Text] [Related]
20. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress. Olcay L, Serteser M, Kolay M, Balci HF, Yildirim ÜM, Tekgündüz SA, Hazirolan T, Terzi YK. J Pediatr Hematol Oncol; 2017 Aug 19; 39(6):425-439. PubMed ID: 28731917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]